{"nct_id":"NCT00722293","title":"A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors","status":"COMPLETED","status_verified_date":"2017-11","start_date":"2008-07-08","start_date_type":"ACTUAL","primary_completion_date":"2012-06-11","primary_completion_date_type":"ACTUAL","completion_date":"2014-02-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}